CLINICAL RHEUMATOLOGY, cilt.41, sa.1, ss.289-296, 2022 (SCI-Expanded)
Objective To document the detailed characteristics including severity, type, and locations of rheumatic and musculoskeletal symptoms along with other COVID-19 persistent symptoms in hospitalized COVID-19 survivors at 3 and 6 months.